Munich Personal RePEc Archive

Cost-containment policies in public pharmaceutical spending in the EU

Carone, Giuseppe and Schwierz, Christoph and Xavier, Ana (2012): Cost-containment policies in public pharmaceutical spending in the EU. Published in: European Economy- Economic Papers , Vol. ISSN 1, No. 461 (14. September 2012): pp. 1-64.

This is the latest version of this item.

[img]
Preview
PDF
MPRA_paper_42008.pdf

Download (1MB) | Preview

Abstract

This paper presents and evaluates pharmaceutical policies in the EU aimed at the rational use of medicines and at keeping pharmaceutical spending under control. Policy makers are growing more aware that by regulating pharmaceutical markets correctly, considerable savings can be achieved without compromising the quality of care. Specifically, the paper makes the case that, by following numerous best-practices in pharmaceutical sector regulations, the value for money of pharmaceutical consumption could be substantially increased. Appropriate regulations can be relevant for pricing, reimbursement, market entry and expenditure control, as well as specific policies targeted at the distribution chain, physicians and patients.

Available Versions of this Item

  • Cost-containment policies in public pharmaceutical spending in the EU. (deposited 21. Oct 2012 05:26) [Currently Displayed]
UB_LMU-Logo
MPRA is a RePEc service hosted by
the Munich University Library in Germany.